https://wikimd.org/index.php?action=history&feed=atom&title=Sarpogrelate 2026-04-26T23:13:20Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.org/index.php?title=Sarpogrelate&diff=6333624&oldid=prev 2025-02-20T01:20:36Z

<p>CSV import</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 01:20, 20 February 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l29">Line 29:</td> <td colspan="2" class="diff-lineno">Line 29:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== External Links ==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== External Links ==</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* [https://www.mt-pharma.co.jp/e/product/prescription/pharmaceuticals/anplag/ Mitsubishi Tanabe Pharma Corporation]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* [https://www.mt-pharma.co.jp/e/product/prescription/pharmaceuticals/anplag/ Mitsubishi Tanabe Pharma Corporation]</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;gallery&gt;</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">File:Sarpogrelate structure.png|Sarpogrelate</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;/gallery&gt;</ins></div></td></tr> </table>

Prab https://wikimd.org/index.php?title=Sarpogrelate&diff=5299928&oldid=prev 2024-02-25T22:14:19Z

<p>CSV import</p> <p><b>New page</b></p><div>&#039;&#039;&#039;Sarpogrelate&#039;&#039;&#039; is a drug that is classified as a [[serotonin]] 2A receptor antagonist. It is primarily used in the treatment of [[Peripheral artery disease|peripheral arterial disease]] (PAD) and [[claudication]]. Sarpogrelate is marketed in Japan and South Korea by Mitsubishi Tanabe Pharma Corporation under the brand name Anplag.<br /> <br /> == Mechanism of Action ==<br /> Sarpogrelate works by inhibiting the action of serotonin on its 2A receptor. This results in a decrease in [[platelet aggregation]], which can help to prevent the formation of [[blood clot]]s. It also has a vasodilatory effect, which can help to improve blood flow in patients with peripheral arterial disease.<br /> <br /> == Uses ==<br /> Sarpogrelate is used in the treatment of peripheral arterial disease and claudication. It can help to improve symptoms such as pain and cramping in the legs that are caused by reduced blood flow.<br /> <br /> == Side Effects ==<br /> Common side effects of sarpogrelate include [[nausea]], [[vomiting]], [[diarrhea]], and [[abdominal pain]]. In rare cases, it can cause serious side effects such as [[bleeding]], [[thrombocytopenia]], and [[leukopenia]].<br /> <br /> == Contraindications ==<br /> Sarpogrelate is contraindicated in patients with a history of [[hypersensitivity]] to the drug or any of its components. It is also contraindicated in patients with severe [[liver disease]] or [[kidney disease]].<br /> <br /> == See Also ==<br /> * [[Peripheral artery disease]]<br /> * [[Serotonin receptor antagonist]]<br /> * [[Platelet aggregation]]<br /> <br /> [[Category:Drugs]]<br /> [[Category:Serotonin receptor antagonists]]<br /> [[Category:Peripheral arterial disease]]<br /> <br /> {{stub}}<br /> <br /> == References ==<br /> &lt;references /&gt;<br /> <br /> == External Links ==<br /> * [https://www.mt-pharma.co.jp/e/product/prescription/pharmaceuticals/anplag/ Mitsubishi Tanabe Pharma Corporation]</div>

Prab